Scott Bruder, MD, PhD, Amendia's board of directors' chairman, will speak at the Harvard Stem Cell Institute and Harvard Business School summit from July 11 to July 13 at Harvard Business School in Boston.
Here are five notes:
1. At the "The Business of Regenerative Medicine: How to Build a Company" conference, Dr. Bruder will sit on a panel to discuss the business of regenerative medicine.
2. Topics will cover biopharmaceutical, device, manufacturing, tissue bank, regulatory and investment sectors.
3. Dr. Bruder will also present on cell therapy and regenerative biomaterial trends, touching on decision-making about bringing biologic products to the market.
4. Dr. Bruder serves as an adjunct professor of biomedical engineering at Case Western Reserve University in Cleveland.
5. Business executives, investors, analysts, technology transfer and development personnel, scientists and government professionals will attend the summit.